These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9803354)

  • 1. The value of pretreatment clinical and biochemical parameters in staging and prognostic stratification of patients with newly diagnosed prostate carcinoma.
    Stokkel MP; Zwinderman AH; Zwartendijk J; Pauwels EK; Van Eck-Smit BL
    Int J Biol Markers; 1998; 13(2):70-6. PubMed ID: 9803354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of pretreatment clinical and biochemical parameters in patients with newly diagnosed untreated prostate carcinoma and no indications for bone metastases on the bone scintigram.
    Stokkel M; Zwinderman A; Zwartendijk J; Pauwels E; van Eck-Smit B
    Eur J Nucl Med; 1997 Oct; 24(10):1215-20. PubMed ID: 9323261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
    Huncharek M; Muscat J
    Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase.
    Wymenga LF; Boomsma JH; Groenier K; Piers DA; Mensink HJ
    BJU Int; 2001 Aug; 88(3):226-30. PubMed ID: 11488734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serum prostate-specific antigen as predictor for bone metastases in newly diagnosed prostate cancer.
    Singh OP; Yogi V; Redhu P; Ghori HU; Pareek A; Lal N
    J Cancer Res Ther; 2019 Mar; 15(Supplement):S39-S41. PubMed ID: 30900618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
    Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer?
    Vijayakumar V; Vijayakumar S; Quadri SF; Blend MJ
    Am J Clin Oncol; 1994 Oct; 17(5):432-6. PubMed ID: 7522394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients.
    Ritenour CW; Abbott JT; Goodman M; Alazraki N; Marshall FF; Issa MM
    ScientificWorldJournal; 2009 Oct; 9():1040-5. PubMed ID: 19802499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
    Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint scintiscans.
    Murphy GP; Snow PB; Brandt J; Elgamal A; Brawer MK
    Prostate; 2000 Feb; 42(2):145-9. PubMed ID: 10617872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
    Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE
    J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
    Morote J; Lorente JA; Encabo G
    Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which patients with prostatic carcinoma require a staging bone scan?
    Kemp PM; Maguire GA; Bird NJ
    Br J Urol; 1997 Apr; 79(4):611-4. PubMed ID: 9126094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
    Gleave ME; Coupland D; Drachenberg D; Cohen L; Kwong S; Goldenberg SL; Sullivan LD
    Urology; 1996 May; 47(5):708-12. PubMed ID: 8650870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of a baseline bone scan in patients with newly diagnosed prostate cancer.
    Lin K; Szabo Z; Chin BB; Civelek AC
    Clin Nucl Med; 1999 Aug; 24(8):579-82. PubMed ID: 10439178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI of the skeleton in prostate cancer staging.
    Rydh A; Lundblad M; Ahlström KR; Tavelin B; Stattin P
    Scand J Urol Nephrol; 2003; 37(3):222-5. PubMed ID: 12775281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer.
    Murphy GP; Troychak MJ; Cobb OE; Bowes VA; Kenny RJ; Barren RJ; Kenny GM; Ragde H; Holmes EH; Wolfert RL
    Prostate; 1997 Oct; 33(2):141-6. PubMed ID: 9316655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.
    Lorente JA; Valenzuela H; Morote J; Gelabert A
    Eur J Nucl Med; 1999 Jun; 26(6):625-32. PubMed ID: 10369948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer.
    Lorente JA; Morote J; Raventos C; Encabo G; Valenzuela H
    J Urol; 1996 Apr; 155(4):1348-51. PubMed ID: 8632571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.